Kargbo Robert B
Usona Institute, Fitchburg, Wisconsin 53711-5300, United States.
ACS Med Chem Lett. 2025 Jan 23;16(2):213-215. doi: 10.1021/acsmedchemlett.5c00029. eCollection 2025 Feb 13.
The intersection of artificial intelligence (AI), digital therapeutics, and advanced communication frameworks offers transformative opportunities for addressing mental health disorders, neurodegenerative diseases, and communication challenges in modern networks. This Patent Highlight examines three pivotal patents that introduce deuterated empathogens for safer psychiatric treatments, AI-powered digital platforms for cognitive and immune function enhancement, and robust frameworks for AI/ML performance monitoring in wireless systems. Together, these innovations represent a paradigm shift in therapeutic and technological approaches, emphasizing the synergy of molecular and digital advancements in tackling global health and communication challenges.
人工智能(AI)、数字疗法和先进通信框架的交叉融合为解决心理健康障碍、神经退行性疾病以及现代网络中的通信挑战提供了变革性机遇。本专利亮点审视了三项关键专利,它们分别介绍了用于更安全精神治疗的氘代共情剂、用于增强认知和免疫功能的人工智能驱动数字平台,以及用于无线系统中人工智能/机器学习性能监测的强大框架。这些创新共同代表了治疗和技术方法的范式转变,强调了分子和数字进步在应对全球健康和通信挑战方面的协同作用。